ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.567,53
-0,31%
S&P 500
5.433,74
0,23%
US Dollar vs BRL
5,3635
0,01%
Bitcoin
66.976,25
0,33%
Brent Oil
82,325
0,43%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cytocom Inc (CBLI)

  7. Cytocom Inc (CBLI) Notícias

CBLI

Cytocom (CBLI)

Cytocom Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBLI
DataHoraFonteTítuloCódigoCompanhia
03/03/202312:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CBLICytocom Inc
27/02/202308:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBLICytocom Inc
15/02/202311:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CBLICytocom Inc
01/02/202318:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBLICytocom Inc
01/02/202318:10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CBLICytocom Inc
14/11/202219:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBLICytocom Inc
06/10/202207:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CBLICytocom Inc
23/09/202207:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CBLICytocom Inc
22/03/202208:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CBLICytocom Inc
21/03/202220:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBLICytocom Inc
15/02/202208:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBLICytocom Inc
30/09/202117:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBLICytocom Inc
31/08/202108:32PR Newswire (US)Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."NASDAQ:CBLICytocom Inc
16/08/202111:34PR Newswire (US)Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via WebcastNASDAQ:CBLICytocom Inc
16/08/202108:30PR Newswire (US)Cytocom, Inc. Reports Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
12/08/202117:05PR Newswire (US)Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance AgreementNASDAQ:CBLICytocom Inc
11/08/202108:30PR Newswire (US)Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business ConferenceNASDAQ:CBLICytocom Inc
10/08/202108:30PR Newswire (US)Cytocom, Inc. to Report Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
09/08/202108:30PR Newswire (US)Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19NASDAQ:CBLICytocom Inc
05/08/202108:33PR Newswire (US)Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabsNASDAQ:CBLICytocom Inc
29/07/202108:33PR Newswire (US)Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt FinancingNASDAQ:CBLICytocom Inc
06/07/202110:16PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed MergerNASDAQ:CBLICytocom Inc
17/06/202119:37PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Decl...NASDAQ:CBLICytocom Inc
11/06/202107:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBLICytocom Inc
17/02/202118:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CBLICytocom Inc
17/02/202118:15PR Newswire (US)Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.NASDAQ:CBLICytocom Inc
22/12/202009:35PR Newswire (US)Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"NASDAQ:CBLICytocom Inc
11/11/202011:11InvestorsHub NewsWireImmune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating OfficerNASDAQ:CBLICytocom Inc
06/11/202019:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBLICytocom Inc
27/10/202014:14InvestorsHub NewsWireImmune Therapeutics, Inc. Announces Cytocom Conference CallNASDAQ:CBLICytocom Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBLI

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
OIBR3
OI ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
AMER3
Americanas ON
BOV
COGN3
COGNA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados